EyePoint, Inc. (EYPT)
12.78
+0.28
(+2.24%)
USD |
NASDAQ |
May 21, 16:00
12.78
0.00 (0.00%)
After-Hours: 19:59
EyePoint Research and Development Expense (TTM) : 234.61M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 220.45M |
| Merck & Co., Inc. | 21.57B |
| Bristol Myers Squibb Co. | 9.494B |
| Arvinas, Inc. | 252.10M |
| Corcept Therapeutics, Inc. | 260.44M |